RNA modifications as emerging therapeutic targets

Area of Science:

• Molecular Biology
• Genetics
• Pharmacology

Background:

• The epitranscriptome, encompassing RNA posttranscriptional modifications, plays a significant role in various diseases.
• Over 170 types of RNA modifications have been identified, highlighting their diverse biological functions.
• Regulatory genes involved in RNA modification are implicated in critical biological processes and disease pathogenesis.

Purpose of the Study:

• To comprehensively review RNA modifications and their regulatory genes in the context of drug development.
• To summarize existing research on targeting RNA modifications for therapeutic interventions.
• To explore the potential of RNA modifications as emerging therapeutic targets.

Main Methods:

• Literature review and synthesis of previous studies on RNA modifications and drug development.
• Analysis of regulatory genes associated with RNA modifications and their roles in disease.
• Discussion of molecular mechanisms for targeting RNA modifications and regulatory genes.

Main Results:

• RNA modifications are increasingly recognized for their involvement in disease development.
• Inhibitors targeting RNA modification regulatory genes demonstrate therapeutic potential.
• A growing body of evidence supports RNA modifications as viable targets for new drug development.

Conclusions:

• RNA modifications and their regulatory genes represent a promising frontier for novel therapeutic strategies.
• Targeting specific RNA modifications or regulatory pathways can offer new avenues for disease treatment.
• Further research into the epitranscriptome holds significant potential for advancing drug discovery and development.